Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KURA Kura Oncology, Inc

已收盘 05-08 16:00:00 EDT

6.00

+0.36

+6.29%

盘后6.00

+0.000.00%

16:05 EDT

最高6.11	最低5.48	成交量99.92万
今开5.65	昨收5.65	日振幅11.16%
总市值5.19亿	流通市值3.94亿	总股本8,657万
成交额592.18万	换手率1.52%	流通股本6,559万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KURA","market":"US","secType":"STK","nameCN":"Kura Oncology, Inc","latestPrice":6,"timestamp":1746734400000,"preClose":5.645,"halted":0,"volume":999201,"hourTrading":{"tag":"盘后","latestPrice":6,"preClose":6,"latestTime":"16:05 EDT","volume":18753,"amount":112518,"timestamp":1746734713010},"delay":0,"floatShares":65588900,"shares":86574687,"eps":-2.08973,"marketStatus":"已收盘","change":0.355,"latestTime":"05-08 16:00:00 EDT","open":5.65,"high":6.11,"low":5.48,"amount":5921820.282076,"amplitude":0.111603,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.08973,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746777600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1446699600000,"exchange":"NASDAQ","adjPreClose":5.645,"preHourTrading":{"tag":"盘前","latestPrice":5.5,"preClose":5.645,"latestTime":"04:18 EDT","volume":99,"amount":544.5,"timestamp":1746692300431},"postHourTrading":{"tag":"盘后","latestPrice":6,"preClose":6,"latestTime":"16:05 EDT","volume":18753,"amount":112518,"timestamp":1746734713010},"volumeRatio":0.673789,"impliedVol":0.843,"impliedVolPercentile":0.764},"requestUrl":"/m/hq/s/KURA","defaultTab":"news","newsList":[{"id":"2533515398","title":"Kura Oncology, Inc.盘中异动 临近午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533515398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533515398?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:47","pubTimestamp":1746719252,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时47分，Kura Oncology, Inc.股票出现异动，股价快速拉升5.05%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为2.36%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Nucana Plc、Gri Bio, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为484.36%、113.46%、58.05%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为87.50%、69.37%、59.60%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于实现精准药物治疗癌症的承诺。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823473294f0aba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823473294f0aba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2533659452","title":"Kura Oncology, Inc.盘中异动 股价大跌5.21%报6.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533659452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533659452?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:42","pubTimestamp":1746546144,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时42分，Kura Oncology, Inc.股票出现异动，股价急速跳水5.21%。截至发稿，该股报6.37美元/股，成交量18.0822万股，换手率0.21%，振幅4.54%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为4.62%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于实现精准药物治疗癌症的承诺。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506234225a474315d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506234225a474315d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KURA","BK4139"],"gpt_icon":0},{"id":"2529386605","title":"Kura Oncology, Inc.盘中异动 早盘快速拉升5.08%报6.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529386605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529386605?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:40","pubTimestamp":1745246459,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时40分，Kura Oncology, Inc.股票出现异动，股价快速上涨5.08%。截至发稿，该股报6.20美元/股，成交量8.0299万股，换手率0.10%，振幅7.06%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于实现精准药物治疗癌症的承诺。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421224100aa2c7470&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421224100aa2c7470&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2517162278","title":"瑞银：维持Kura Oncology(KURA.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至14.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162278","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162278?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:05","pubTimestamp":1741277144,"startTime":"0","endTime":"0","summary":"瑞银：维持Kura Oncology(KURA.US)评级，由买入调整至买入评级, 目标价由27.00美元调整至14.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07000548577058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KURA"],"gpt_icon":0},{"id":"2516169663","title":"Kura Oncology, Inc.盘中异动 下午盘急速跳水5.06%报7.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516169663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516169663?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:27","pubTimestamp":1741033650,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时27分，Kura Oncology, Inc.股票出现波动，股价快速跳水5.06%。截至发稿，该股报7.32美元/股，成交量75.0327万股，换手率0.93%，振幅7.33%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042731989a5f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042731989a5f18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KURA","BK4139"],"gpt_icon":0},{"id":"2516548051","title":"Kura Oncology, Inc.2024财年实现净利润-1.74亿美元，同比减少13.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516548051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516548051?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931271,"startTime":"0","endTime":"0","summary":"3月3日，Kura Oncology, Inc.公布财报，公告显示公司2024财年净利润为-1.74亿美元，同比减少13.73%；其中营业收入为53.88百万美元，每股基本收益为-2.02美元。从资产负债表来看，Kura Oncology, Inc.总负债6.27亿美元，其中短期债务4.49百万美元，资产负债比为1.67，流动比率为0.10。机构评级：截至2025年3月3日，当前有12家机构对Kura Oncology, Inc.目标价做出预测，其中目标均价为27.75美元，其中最低目标价为10.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000150abe4acd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000150abe4acd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA"],"gpt_icon":0},{"id":"1110051286","title":"异动解读 | Kura Oncology财报超预期,盘后股价大涨6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110051286","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110051286?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:53","pubTimestamp":1740606783,"startTime":"0","endTime":"0","summary":"Kura Oncology公司(KURA)在2025年2月26日星期三的盘后交易中股价大涨6.69%,引起市场广泛关注。\n\n公司发布的最新财报数据显示,其第四季度GAAP每股亏损为0.22美元,优于分析师一致预期的0.65美元亏损,超出预期幅度高达66.15%;同时,公司季度销售额达到5388万美元,远高于市场预期的850万美元,增长幅度超过533.92%。\n\n财报数据明显超出市场预期,反映出公司业绩和发展势头良好,投资者对此反应积极,推动了公司股价在盘后市场的大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KURA"],"gpt_icon":0},{"id":"1132024829","title":"Kura Oncology第四季度GAAP每股亏损$(0.22)优于预期$(0.65)，销售额达$53.88M远超预期$8.50M","url":"https://stock-news.laohu8.com/highlight/detail?id=1132024829","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132024829?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:36","pubTimestamp":1740605792,"startTime":"0","endTime":"0","summary":"Kura Oncology报告称，其季度每股亏损$，优于分析师一致预期的$，超出预期66.15%。相比去年同期每股亏损$，同比改善60%。公司报告季度销售额为$53.88M，远超分析师预期的$8.50M，增长533.92%。以上内容来自Benzinga Earnings专栏，原文如下：Kura Oncology  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 66.15 percent. This is a 60 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $53.88 million which beat the analyst consensus estimate of $8.50 million by 533.92 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Kura Oncology第四季度GAAP每股亏损$(0.22)优于预期$(0.65)，销售额达$53.88M远超预期$8.50M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA"],"gpt_icon":0},{"id":"2510332698","title":"Kura Oncology, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510332698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510332698?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:49","pubTimestamp":1739292574,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时49分，Kura Oncology, Inc.股票出现异动，股价快速下挫5.01%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.45%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Oramed Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2984.89%、1321.42%、435.90%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.46%、58.60%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120049359881d4b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120049359881d4b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2509272661","title":"Kura Oncology, Inc.盘中异动 股价大跌12.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272661","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509272661?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，Kura Oncology, Inc.股票出现波动，股价急速跳水12.04%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3890.21%、340.23%、114.95%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Rani Therapeutics Holdings, Inc.、Relmada Therapeutics, Inc.，振幅分别为33.33%、15.97%、14.26%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223215abc4d4a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223215abc4d4a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2509170464","title":"Kura Oncology, Inc.盘中异动 股价大涨5.09%报8.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509170464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509170464?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:52","pubTimestamp":1738687969,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时52分，Kura Oncology, Inc.股票出现波动，股价快速上涨5.09%。截至发稿，该股报8.67美元/股，成交量92.6882万股，换手率1.19%，振幅7.52%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.34%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205005250abc242f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205005250abc242f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2508124353","title":"Kura Oncology, Inc.盘中异动 下午盘股价大涨5.06%报8.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508124353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508124353?lang=zh_cn&edition=full","pubTime":"2025-02-04 02:44","pubTimestamp":1738608290,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日02时44分，Kura Oncology, Inc.股票出现波动，股价急速拉升5.06%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Hcw Biologics Inc.、Invivyd, Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为717.48%、662.83%、467.97%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、151.80%、63.94%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204024450abc13978&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204024450abc13978&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2507767539","title":"Kura Oncology, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507767539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507767539?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:57","pubTimestamp":1738256260,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时57分，Kura Oncology, Inc.股票出现异动，股价快速上涨5.07%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1676.96%、250.03%、221.87%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为65.98%、61.86%、56.73%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131005741a2346e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131005741a2346e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2505708704","title":"Kura Oncology, Inc.盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505708704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505708704?lang=zh_cn&edition=full","pubTime":"2025-01-23 04:18","pubTimestamp":1737577118,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日04时18分，Kura Oncology, Inc.股票出现异动，股价急速拉升5.01%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Eterna Therapeutics Inc.、Immunoprecise Antibodies Ltd.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为1030.17%、464.21%、96.98%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Immunoprecise Antibodies Ltd.、Immatics N V C/Wts 01/07/2025 ，振幅分别为68.99%、60.53%、53.51%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123041838a22bf969&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123041838a22bf969&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KURA","BK4139"],"gpt_icon":0},{"id":"2503425706","title":"Kura Oncology, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503425706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503425706?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951537,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Kura Oncology, Inc.股票出现异动，股价急速上涨5.10%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.06%、52.88%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为14.29%、12.00%、10.72%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223218a222fe16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223218a222fe16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2502607048","title":"Kura Oncology, Inc.盘中异动 快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502607048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502607048?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:00","pubTimestamp":1736521241,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时00分，Kura Oncology, Inc.股票出现异动，股价急速跳水5.01%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Moolec Science Sa C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1084.50%、276.27%、188.88%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为64.51%、41.78%、37.29%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102300419861f010&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102300419861f010&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2502170455","title":"Kura Oncology, Inc.盘中异动 股价大跌5.14%报7.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502170455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502170455?lang=zh_cn&edition=full","pubTime":"2025-01-09 03:03","pubTimestamp":1736363021,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日03时03分，Kura Oncology, Inc.股票出现异动，股价急速跳水5.14%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3548.25%、612.79%、598.69%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、153.20%、89.00%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109030342985fa375&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109030342985fa375&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2501727729","title":"Scotiabank：维持Kura Oncology(KURA.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由18.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501727729","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501727729?lang=zh_cn&edition=full","pubTime":"2025-01-08 21:52","pubTimestamp":1736344334,"startTime":"0","endTime":"0","summary":"Scotiabank：维持Kura Oncology(KURA.US)评级，由与大盘持平调整至与大盘持平评级, 目标价由18.00美元调整至10.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/08215247277179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KURA"],"gpt_icon":0},{"id":"2492582721","title":"Kura Oncology, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492582721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492582721?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:30","pubTimestamp":1734550237,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时30分，Kura Oncology, Inc.股票出现波动，股价快速下跌5.03%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.61%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3152.24%、649.65%、345.21%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、127.32%、105.17%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903303795ea590e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903303795ea590e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2491305023","title":"Kura Oncology, Inc.盘中异动 大幅下跌5.00%报9.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491305023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491305023?lang=zh_cn&edition=full","pubTime":"2024-12-13 01:59","pubTimestamp":1734026349,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日01时59分，Kura Oncology, Inc.股票出现异动，股价大幅下跌5.00%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，Trevi Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为3871.42%、88.10%、79.70%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Palisade Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为129.16%、99.29%、86.92%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121301591095e93e25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121301591095e93e25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KURA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kuraoncology.com","stockEarnings":[{"period":"1week","weight":-0.1395},{"period":"1month","weight":-0.02},{"period":"3month","weight":-0.36},{"period":"6month","weight":-0.6807},{"period":"1year","weight":-0.7321},{"period":"ytd","weight":-0.3519}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.1126},{"period":"3month","weight":-0.0745},{"period":"6month","weight":-0.0619},{"period":"1year","weight":0.0851},{"period":"ytd","weight":-0.0425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kura Oncology, Inc.最初于2007年11月在特拉华州注册成立。他们是一家临床阶段的生物制药公司，致力于实现精准药物治疗癌症的前景。他们的产品线由针对癌症信号通路的小分子候选产品组成，在这些信号通路中，有很强的科学和临床理由来改善结果，他们打算将其与分子或细胞诊断相结合，以确定最有可能对治疗做出反应的患者。他们正在对三种候选产品进行临床试验：齐夫托米尼、替比法尼和KO-2806。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.024387},{"month":2,"riseRate":0.5,"avgChangeRate":0.027496},{"month":3,"riseRate":0.6,"avgChangeRate":-0.029894},{"month":4,"riseRate":0.2,"avgChangeRate":-0.031764},{"month":5,"riseRate":0.5,"avgChangeRate":0.014435},{"month":6,"riseRate":0.444444,"avgChangeRate":0.040223},{"month":7,"riseRate":0.444444,"avgChangeRate":0.036126},{"month":8,"riseRate":0.444444,"avgChangeRate":0.040112},{"month":9,"riseRate":0.444444,"avgChangeRate":0.121116},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.10353},{"month":11,"riseRate":0.777778,"avgChangeRate":0.037745},{"month":12,"riseRate":0.5,"avgChangeRate":0.018452}],"exchange":"NASDAQ","name":"Kura Oncology, Inc","nameEN":"Kura Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kura Oncology, Inc(KURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kura Oncology, Inc,KURA,Kura Oncology, Inc股票,Kura Oncology, Inc股票老虎,Kura Oncology, Inc股票老虎国际,Kura Oncology, Inc行情,Kura Oncology, Inc股票行情,Kura Oncology, Inc股价,Kura Oncology, Inc股市,Kura Oncology, Inc股票价格,Kura Oncology, Inc股票交易,Kura Oncology, Inc股票购买,Kura Oncology, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kura Oncology, Inc(KURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况